Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni L Ceresoli

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucoseGiovanni L Ceresoli, Arturo Chiti, Paolo A Zucali, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2011
Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesotheliomaGiovanni L Ceresoli, Paolo A Zucali, Fabio De Vincenzo, et al.
Expert Opinion on Medical Diagnostics|March 16, 2013
EGFR tyrosine kinase inhibitors: a therapy for a few, for the majority or for all non-small cell lung cancer patients?Giovanna Finocchiaro, Luca Toschi, Isabella Garassino, et al.
Tumori|July 22, 2017
Significance of neutrophil-to-lymphocyte ratio in Western advanced EGFR-mutated non-small cell lung cancer receiving a targeted therapyFausto Meriggi, Claudio Codignola, Giordano D Beretta, et al.
Cancer Treatment Reviews|September 4, 2007
Assessment of tumor response in malignant pleural mesotheliomaGiovanni L Ceresoli, Arturo Chiti, Paolo A Zucali, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2020
Salvage radiotherapy for oligo-progressive malignant pleural mesotheliomaPaolo Ghirardelli, Davide Franceschini, Alessandro D'Aveni, et al.
Cancer|February 21, 2008
Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesotheliomaPaolo A Zucali, Giovanni L Ceresoli, Isabella Garassino, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2007
Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-upAnnarita Destro, Giovanni L Ceresoli, Ekaterina Baryshnikova, et al.
Cell Death & Disease|July 15, 2022
Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulationsLaura Mannarino, Federica Mirimao, Nicolò Panini, et al.
Oncology Research and Treatment|May 5, 2017
Clinical Features and Treatment Outcome of Malignant Pleural MesotheliomaManlio Mencoboni, Rosa A Filiberti, Paola Taveggia, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucoseGiovanni L Ceresoli, Arturo Chiti, Paolo A Zucali, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2011
Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesotheliomaGiovanni L Ceresoli, Paolo A Zucali, Fabio De Vincenzo, et al.
Expert Opinion on Medical Diagnostics|March 16, 2013
EGFR tyrosine kinase inhibitors: a therapy for a few, for the majority or for all non-small cell lung cancer patients?Giovanna Finocchiaro, Luca Toschi, Isabella Garassino, et al.
Tumori|July 22, 2017
Significance of neutrophil-to-lymphocyte ratio in Western advanced EGFR-mutated non-small cell lung cancer receiving a targeted therapyFausto Meriggi, Claudio Codignola, Giordano D Beretta, et al.
Cancer Treatment Reviews|September 4, 2007
Assessment of tumor response in malignant pleural mesotheliomaGiovanni L Ceresoli, Arturo Chiti, Paolo A Zucali, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2020
Salvage radiotherapy for oligo-progressive malignant pleural mesotheliomaPaolo Ghirardelli, Davide Franceschini, Alessandro D'Aveni, et al.
Cancer|February 21, 2008
Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesotheliomaPaolo A Zucali, Giovanni L Ceresoli, Isabella Garassino, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2007
Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-upAnnarita Destro, Giovanni L Ceresoli, Ekaterina Baryshnikova, et al.
Cell Death & Disease|July 15, 2022
Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulationsLaura Mannarino, Federica Mirimao, Nicolò Panini, et al.
Oncology Research and Treatment|May 5, 2017
Clinical Features and Treatment Outcome of Malignant Pleural MesotheliomaManlio Mencoboni, Rosa A Filiberti, Paola Taveggia, et al.
Pageof 2